Mankind Pharma Partners with Chongqing Chenan Biopharmaceutical to Distribute Insulin Degludec in India

Mankind Pharma has entered into a formal agreement with Chongqing Chenan Biopharmaceutical to introduce two insulin analogues to the Indian market. The partnership grants the Indian pharmaceutical company the rights to market and distribute Insulin Degludec and the Insulin Degludec plus Aspart combination within the country. This collaboration focuses on expanding the availability of these…